An investor analysis ranks five Lilly milestones by return. The 2008 ImClone deal turned $1,000 into about $58,000, while buying at Zepbound's approval returned 91%.
Recap by typeshit. Full story at Yahoo Finance.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Pooling six trials with 3,459 adults, researchers saw bigger drops in weight, HbA1c and blood pressure at the higher dose. They flag small liver enzyme rises to monitor.
A 2022 PLOS ONE study found 63.2% of people reported needle phobia. BioNxt is working on a sublingual semaglutide film, though such formats aren't FDA approved.
Loading…